Exploring Potential of Topical Acitretin Transferosomal Formulation for Management of Psoriasis: In vitro and In vivo Analysis

Key Points

• The topical acitretin transferosomal formulation shows enhanced drug delivery and efficacy in psoriasis treatment.
• The analysis reveals a 30% improvement in skin condition over 8 weeks for patients using the transferosomal formulation compared to standard treatments.
• In vitro and in vivo studies were conducted to assess the formulation's performance and skin absorption rate.
• Further clinical trials are needed to validate effectiveness and overall patient outcomes beyond preliminary findings.